Epithelial/Mesenchymal Characteristics and PD-L1 Co-Expression in CTCs of Metastatic Breast Cancer Patients Treated with Eribulin: Correlation with Clinical Outcome

Epithelial/Mesenchymal Characteristics and PD-L1 Co-Expression in CTCs of Metastatic Breast Cancer Patients Treated with Eribulin: Correlation with Clinical Outcome

We aimed to evaluate the co-expression of PD-L1 and epithelial-mesenchymal markers in CTCs from metastatic breast cancer (MBC) patients and to determine if there is any relationship with patients’ outcome after eribulin treatment. Using cytospin preparations of peripheral blood mononuclear cells (PB...

Full description

Bibliographic Details
Main Authors: Hara Polioudaki, Anastasia Mala, Eleni Gkimprixi, Maria A. Papadaki, Amanda Chantziou, Maria Tzardi, Dimitris Mavroudis, Sofia Agelaki, Panayiotis A. Theodoropoulos
Format: Article
Language:English
Published: MDPI AG 2020-12-01
Series:Cancers
Subjects:
metastatic breast cancer
CTCs
eribulin
PD-L1
EMT status
MET
Online Access:https://www.mdpi.com/2072-6694/12/12/3735

Internet

https://www.mdpi.com/2072-6694/12/12/3735

Similar Items